Cargando…

Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies

Gallbladder cancer (GBC) mortality remains high and chemoresistance is increasing. This review consolidates what is known about the mechanisms of chemoresistance to inform and accelerate the development of novel GBC-specific chemotherapies. METHODS: Studies related to GBC-related chemoresistance wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Jinbao, Yang, Songlin, Lin, Zhuying, Huang, Wenwen, Li, Xiao, Li, Ruhong, Tan, Jing, Wang, Wenju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030176/ https://www.ncbi.nlm.nih.gov/pubmed/36867653 http://dx.doi.org/10.1097/COC.0000000000000989

Ejemplares similares

OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis
por: Lin, Zhuying, et al.
Publicado: (2021)

Novel strategies to reverse chemoresistance in colorectal cancer
por: Ma, Shu‐Chang, et al.
Publicado: (2023)

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma
por: Chen, Tingting, et al.
Publicado: (2022)

Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer
por: Patel, Amol, et al.
Publicado: (2020)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery
por: Li, Xiao, et al.
Publicado: (2022)

Gallbladder Cancer Progression Is Reversed by Nanomaterial-Induced Photothermal Therapy in Combination with Chemotherapy and Autophagy Inhibition
por: Cai, Qiang, et al.
Publicado: (2020)

Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer
por: Talwar, Vineet, et al.
Publicado: (2020)

Gallbladder Cancer Progression is Reversed by Nanomaterial-Induced Photothermal Therapy in Combination with Chemotherapy and Autophagy Inhibition [Retraction]
Publicado: (2023)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
por: Chen, Xun, et al.
Publicado: (2020)

Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis
por: Fukuda, Akito, et al.
Publicado: (2022)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Self-Assembled Daunorubicin/Epigallocatechin Gallate Nanocomplex for Synergistic Reversal of Chemoresistance in Leukemia
por: Bae, Ki Hyun, et al.
Publicado: (2022)

Update in clinical management for gallbladder neuroendocrine carcinoma
por: Chu, Hongwu, et al.
Publicado: (2021)

Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy
por: Cai, Qiang, et al.
Publicado: (2019)

Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α
por: Pan, Yue, et al.
Publicado: (2017)

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
por: Ricciardelli, Carmela, et al.
Publicado: (2013)

Adjuvant and first line chemotherapy use for endometrial cancer
por: Knisely, Anne, et al.
Publicado: (2022)

Correction: Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy
por: Cai, Qiang, et al.
Publicado: (2022)

Correction: Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy
por: Cai, Qiang, et al.
Publicado: (2023)

Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines
por: Busch, Maike, et al.
Publicado: (2018)

SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
por: Gao, Wujiang, et al.
Publicado: (2022)

Editorial: New strategies to tackle chemoresistance in cancer
por: De Marco, Carmela, et al.
Publicado: (2022)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Nanomedicine strategies to counteract cancer stemness and chemoresistance
por: Liu, Huayu, et al.
Publicado: (2023)

Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
por: Christos, Steve, et al.
Publicado: (2016)

Gallbladder perforation: a rare complication of postoperative chemotherapy of gastric cancer
por: Sun, Yanlai, et al.
Publicado: (2015)

Long Non-Coding RNA Myosin Light Chain Kinase Antisense 1 Plays an Oncogenic Role in Gallbladder Carcinoma by Promoting Chemoresistance and Proliferation
por: Li, Yongliang, et al.
Publicado: (2021)

Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells
por: Liu, Tian-Yu, et al.
Publicado: (2013)

Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
por: Orza, Anamaria, et al.
Publicado: (2013)

P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors
por: Kopecka, Joanna, et al.
Publicado: (2016)

Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
por: Xu, Jin-Feng, et al.
Publicado: (2021)

An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance
por: Carta, Alessia, et al.
Publicado: (2014)

Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update
por: Sharma, Aarti, et al.
Publicado: (2017)

Essential updates 2019/2020: Surgical treatment of gallbladder cancer
por: Matsuyama, Ryusei, et al.
Publicado: (2021)

Reviewing the potential role of radiation therapy in gallbladder cancer: an update
por: Kumar, Divyesh, et al.
Publicado: (2022)

Update on first-line treatment of advanced ovarian carcinoma
por: Kemp, Z, et al.
Publicado: (2013)

Economic Evaluation of First-Line Adjuvant Chemotherapies for Resectable Gastric Cancer Patients in China
por: Tan, Chongqing, et al.
Publicado: (2013)

miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
por: Chen, Xuesong, et al.
Publicado: (2016)

Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway
por: Zhang, Jian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ocedscb4c85f7uvqd511lfutvu